{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-06",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0024-5761",
      "generic_name": "insulin glargine and lixisenatide",
      "labeler_name": "Sanofi-Aventis U.S. LLC",
      "brand_name": "Soliqua 100/33",
      "active_ingredients": [
        {
          "name": "INSULIN GLARGINE",
          "strength": "100 U/mL"
        },
        {
          "name": "LIXISENATIDE",
          "strength": "33 ug/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0024-5761-01",
          "description": "1 SYRINGE in 1 CARTON (0024-5761-01)  / 3 mL in 1 SYRINGE",
          "marketing_start_date": "20161121",
          "sample": false
        },
        {
          "package_ndc": "0024-5761-05",
          "description": "5 SYRINGE in 1 CARTON (0024-5761-05)  / 3 mL in 1 SYRINGE (0024-5761-02)",
          "marketing_start_date": "20161121",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Sanofi-Aventis U.S. LLC"
        ],
        "rxcui": [
          "1858995",
          "1859000"
        ],
        "spl_set_id": [
          "4bba538b-cf7c-4310-ae8f-cb711ed21bcc"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "M0011417",
          "N0000175453",
          "N0000178480",
          "M0160181",
          "N0000020058"
        ],
        "pharm_class_cs": [
          "Insulin [CS]",
          "Glucagon-Like Peptide 1 [CS]"
        ],
        "pharm_class_epc": [
          "Insulin Analog [EPC]",
          "GLP-1 Receptor Agonist [EPC]"
        ],
        "pharm_class_moa": [
          "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
        ],
        "unii": [
          "2ZM8CX04RZ",
          "74O62BB01U"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "dd3cca75-32f2-4e6d-8121-20f47e101495",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20161121",
      "product_id": "0024-5761_dd3cca75-32f2-4e6d-8121-20f47e101495",
      "application_number": "BLA208673",
      "brand_name_base": "Soliqua 100/33",
      "pharm_class": [
        "GLP-1 Receptor Agonist [EPC]",
        "Glucagon-Like Peptide 1 [CS]",
        "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",
        "Insulin Analog [EPC]",
        "Insulin [CS]"
      ]
    }
  ]
}